Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson’s disease
Objective: To investigate the relationship between ventral striatum D3 dopamine receptor availability and severity of impulse control disorder (ICD) in Parkinson’s disease (PD). Background: Reduced…Triggers and Alleviating Factors for Fatigue in Parkinson’s Disease
Objective: To examine self-reported triggers of fatigue for individuals with Parkinson’s Disease (PD), the strategies they employ to cope with fatigue, and the types of…Rates of Pharmacological Treatment of Neuropsychiatric Symptoms in Early Parkinson’s Disease
Objective: To determine the rates of pharmacological treatment for neuropsychiatric symptoms (NPS) in patients with early Parkinson’s disease (PD), and identify predictors of under-treatment. Background:…“Familial imprint” of Parkinson disease: the siblings’ cohort of PROPAG-AGEING
Objective: To verify if non-affected siblings (Sibs) of PD patients share candidate PD biomarkers in comparison with de-novo PD patients (PD) and healthy controls (HC).…Data quality, acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)
Objective: To analyze the acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS). Background: Parkinson’s disease (PD) is a chronic…Quantitative Susceptibility Mapping: an Biomarker for Diagnosis of Parkinson’s Disease and Evaluation Patients’ Condition
Objective: To study deep gray matter susceptibility in Parkinson's Disease (PD) by using quantitative susceptibility mapping (QSM) and to assess the relationship between susceptibility value…Levodopa/carbidopa Intestinal Gel in Treatment of Non-Motor Symptoms in Advanced Parkinson’s Disease
Objective: To identify the advantages of LCIG in the treatment of NMS among APD patients and appraise the currently available literature to identify the gaps…Carotid Intima-Media Thickness and its correlates in people with Parkinson’s disease: a pilot study
Objective: To determine the clinical correlates of carotid intima media thickess in patients with idiopathic Parkinson’s disease (PD). Background: Subclinical cardiovascular disease has been suggested…Hyposmia as a marker of (non-)motor disease progression in Parkinson’s disease
Objective: To determine the relationship of anosmia/hyposmia in Parkinson’s disease (PD) with other motor and non-motor symptoms, and with the degree of nigrostriatal dopaminergic cell…Developing an innovative telephone support line for people with Parkinson’s Disease
Objective: To develop a novel care approach using a nurse led telephone helpline specialized and dedicated to persons with Parkinson’s Disease (PD). Background: PD is…
- « Previous Page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- …
- 51
- Next Page »